Related Experiment Video
Updated: May 3, 2026

Murine Fecal Isolation and Microbiota Transplantation
Published on: May 26, 2023
Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes
S D Udayappan1, A V Hartstra, G M Dallinga-Thie
1Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Abstract:
The prevalence of obesity and diabetes mellitus type 2 is increasing rapidly around the globe. Recent insights have generated an entirely new perspective that the intestinal microbiota may play a significant role in the development of these metabolic disorders. Alterations in the intestinal microbiota composition promote systemic inflammation that is a hallmark of obesity and subsequent insulin resistance. Thus, it is important to understand the reciprocal relationship between intestinal microbiota composition and metabolic health in order to eventually prevent disease progression. In this respect, faecal transplantation studies have implicated that butyrate-producing intestinal bacteria are crucial in this process and be considered as key players in regulating diverse signalling cascades associated with human glucose and lipid metabolism.
Related Concept Videos
Type II Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
What is Monogastric Digestion?
Type I Diabetes II: Pathophysiology
Functions of the Gut Microbiota
Microbiota of the Large Intestine

